New Zealand markets open in 6 hours 29 minutes

Cosmos Health Inc. (V67A.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.6380+0.0025 (+0.39%)
As of 08:08AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 10.86M
Enterprise value 18.95M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.14
Price/book (mrq)0.26
Enterprise value/revenue 0.41
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.83
52-week change 3-79.23%
S&P500 52-week change 327.84%
52-week high 33.6600
52-week low 30.4478
50-day moving average 30.6145
200-day moving average 30.9421

Share statistics

Avg vol (3-month) 316
Avg vol (10-day) 3N/A
Shares outstanding 516.85M
Implied shares outstanding 617.09M
Float 811.88M
% held by insiders 113.04%
% held by institutions 13.57%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 316 Dec 2022

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin -31.48%
Operating margin (ttm)-23.53%

Management effectiveness

Return on assets (ttm)-16.58%
Return on equity (ttm)-62.79%

Income statement

Revenue (ttm)49.59M
Revenue per share (ttm)5.07
Quarterly revenue growth (yoy)6.70%
Gross profit (ttm)N/A
EBITDA -15.34M
Net income avi to common (ttm)-42.91M
Diluted EPS (ttm)-3.9000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.38M
Total cash per share (mrq)0.18
Total debt (mrq)10.79M
Total debt/equity (mrq)24.20%
Current ratio (mrq)2.06
Book value per share (mrq)3.40

Cash flow statement

Operating cash flow (ttm)-26.91M
Levered free cash flow (ttm)-20.46M